Association of Multifocality With Prognosis of Papillary Thyroid Carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries., CA Cancer J Clin, 68, 394, 10.3322/caac.v68.6
Hong, 2020, Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017., Cancer Res Treat, 52, 335, 10.4143/crt.2020.206
Ito, 2010, An observational trial for papillary thyroid microcarcinoma in Japanese patients., World J Surg, 34, 28, 10.1007/s00268-009-0303-0
Cho, 2013, Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades., Thyroid, 23, 797, 10.1089/thy.2012.0329
Mazzaferri, 2007, Management of low-risk differentiated thyroid cancer., Endocr Pract, 13, 498, 10.4158/EP.13.5.498
Suh, 2015, Factors affecting the locoregional recurrence of conventional papillary thyroid carcinoma after surgery: a retrospective analysis of 3381 patients., Ann Surg Oncol, 22, 3543, 10.1245/s10434-015-4448-9
Hay, 1993, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989., Surgery, 114, 1050
Li, 2020, The impact of BRAF mutation on the recurrence of papillary thyroid carcinoma: a meta-analysis., Cancers (Basel), 12, 10.3390/cancers12082056
Kuhn, 2012, Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature., Endocr Pathol, 23, 101, 10.1007/s12022-012-9202-2
Geron, 2019, Multifocality is not an independent prognostic factor in papillary thyroid cancer: a propensity score-matching analysis., Thyroid, 29, 513, 10.1089/thy.2018.0547
Joseph, 2018, Multifocality as a prognostic factor in thyroid cancer: a meta-analysis., Int J Surg, 50, 121, 10.1016/j.ijsu.2017.12.035
Vuong, 2018, Clinicopathological risk factors for distant metastasis in differentiated thyroid carcinoma: a meta-analysis., World J Surg, 42, 1005, 10.1007/s00268-017-4206-1
Qu, 2016, Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature., Tumour Biol, 37, 7797, 10.1007/s13277-015-4532-6
Markovic, 2018, Multifocality as independent prognostic factor in papillary thyroid cancer: a multivariate analysis., J BUON, 23, 1049
Guo, 2014, Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis., Int J Clin Exp Pathol, 7, 5393
Kim, 2020, Cystic lateral lymph node metastases from papillary thyroid cancer patients., Laryngoscope, 130, E976, 10.1002/lary.28631
Wang, 2017, The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer., J Clin Endocrinol Metab, 102, 3241, 10.1210/jc.2017-00277
Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement., BMJ, 339, b2535, 10.1136/bmj.b2535
Tierney, 2007, Practical methods for incorporating summary time-to-event data into meta-analysis., Trials, 8, 16, 10.1186/1745-6215-8-16
Ahn, 2020, Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma., Br J Surg, 107, 687, 10.1002/bjs.11430
Feng, 2020, Significance of multifocality in papillary thyroid carcinoma., Eur J Surg Oncol, 46, 1820, 10.1016/j.ejso.2020.06.015
Jiang, 2020, Predictive risk-scoring model for central lymph node metastasis and predictors of recurrence in papillary thyroid carcinoma., Sci Rep, 10, 710, 10.1038/s41598-019-55991-1
Shin, 2020, Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma., Am J Surg, 220, 925, 10.1016/j.amjsurg.2020.02.020
Wang, 2020, Unilateral Tnm T1 and T2 thyroid papillary carcinoma with lateral cervical lymph node metastasis: total thyroidectomy or lobectomy?, Endocr Pract, 26, 1085, 10.4158/EP-2020-0125
Byeon, 2019, Clinical analysis of pediatric thyroid cancer: a single medical institution experience of 18?years., Ann Otol Rhinol Laryngol, 128, 1152, 10.1177/0003489419868251
Khan, 2018, Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression., Updates Surg, 70, 121, 10.1007/s13304-017-0465-5
Palaniappan, 2018, Management outcomes of pediatric and adolescent papillary thyroid cancers with a brief review of literature., Indian J Cancer, 55, 105, 10.4103/ijc.IJC_486_17
Ryu, 2018, Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection., World J Surg Oncol, 16, 205, 10.1186/s12957-018-1496-1
Sun, 2017, Lymph node characteristics for predicting locoregional recurrence of papillary thyroid cancer in adolescents and young adults., Oral Oncol, 66, 22, 10.1016/j.oraloncology.2016.12.028
Xue, 2017, Radioactive iodine ablation decrease recurrences in papillary thyroid microcarcinoma with lateral lymph node metastasis in chinese patients., World J Surg, 41, 3139, 10.1007/s00268-017-4134-0
Kim, 2016, Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma., Endocr Relat Cancer, 23, 367, 10.1530/ERC-15-0572
Lang, 2016, Postoperative nomogram for predicting disease-specific death and recurrence in papillary thyroid carcinoma., Head Neck, 38, E1256, 10.1002/hed.24201
Lim, 2016, Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis., Oral Oncol, 62, 109, 10.1016/j.oraloncology.2016.10.010
Kim, 2015, Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients., Ann Surg Oncol, 22, 125, 10.1245/s10434-014-3899-8
Lee, 2015, Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years., J Clin Endocrinol Metab, 100, 1619, 10.1210/jc.2014-3647
Fridman, 2014, Initial presentation and late results of treatment of post-Chernobyl papillary thyroid carcinoma in children and adolescents of Belarus., J Clin Endocrinol Metab, 99, 2932, 10.1210/jc.2013-3131
Lee, 2014, Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma., J Surg Oncol, 109, 168, 10.1002/jso.23447
Qu, 2014, Number of tumor foci predicts prognosis in papillary thyroid cancer., BMC Cancer, 14, 914, 10.1186/1471-2407-14-914
Grogan, 2013, A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up., Surgery, 154, 1436, 10.1016/j.surg.2013.07.008
Buffet, 2012, Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma., Eur J Endocrinol, 167, 267, 10.1530/EJE-12-0105
Zuniga, 2009, Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma., Arch Otolaryngol Head Neck Surg, 135, 1087, 10.1001/archoto.2009.163
Iacobone, 2014, Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES)., Langenbecks Arch Surg, 399, 141, 10.1007/s00423-013-1145-7
Wang, 2016, Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis., Eur J Clin Invest, 46, 146, 10.1111/eci.2016.46.issue-2
Zhang, 2016, Meta-analyses of association between BRAF(V600E) mutation and clinicopathological features of papillary thyroid carcinoma., Cell Physiol Biochem, 38, 763, 10.1159/000443032
Haugen, 2016, 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer.., Thyroid, 26, 1, 10.1089/thy.2015.0020
Pacini, 2006, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium., Eur J Endocrinol, 154, 787, 10.1530/eje.1.02158
Filetti, 2019, Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up., Ann Oncol, 30, 1856, 10.1093/annonc/mdz400
Kim, 2013, Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma., World J Surg, 37, 376, 10.1007/s00268-012-1835-2
Ng, 2017, Therapeutic outcomes of patients with multifocal papillary thyroid microcarcinomas and larger tumors., Int J Endocrinol, 2017, 10.1155/2017/4208178
Kim, 2015, Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma., Head Neck, 37, 650, 10.1002/hed.v37.5
Lu, 2016, Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles., J Pathol, 239, 72, 10.1002/path.4696
Lin, 2009, High recurrent rate of multicentric papillary thyroid carcinoma., Ann Surg Oncol, 16, 2609, 10.1245/s10434-009-0565-7
Mazeh, 2011, Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy., Am J Surg, 201, 770, 10.1016/j.amjsurg.2010.03.004
Tam, 2016, Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer., Endocrine, 53, 774, 10.1007/s12020-016-0955-0
Wells? GA, Shea? B, O’Connell? D, The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Accessed August 20, 2020. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp